|
MechanismCSF-1R antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date16 Dec 2025 |
100 Clinical Results associated with Merck Serono (Beijing) Pharmaceutical Distribution Co., Ltd.
0 Patents (Medical) associated with Merck Serono (Beijing) Pharmaceutical Distribution Co., Ltd.
100 Deals associated with Merck Serono (Beijing) Pharmaceutical Distribution Co., Ltd.
100 Translational Medicine associated with Merck Serono (Beijing) Pharmaceutical Distribution Co., Ltd.